By increasing muscle loss and decreasing cardiorespiratory fitness, weight-loss drugs can negatively affect mortality risk, ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

A breakthrough has been made in weight-loss drugs after scientists discovered a new medication – known as TDP – that works ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

A study finds that adjunctive use of GLP-1 receptor agonists before and after undergoing bariatric surgery produces greater ...

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.